Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss)

Ferrari Stefano; Meazza Cristina; Palmerini Emanuela; Tamburini Angela; Fagioli Franca; Cozza Raffaele; Ferraresi Virginia; Bisogno Gianni; Mascarin Maurizio; Cefalo Graziella; Manfrini Marco; Capanna Rodolfo; Biagini Roberto; Donati Davide; Picci Piero

首页> 外文期刊>Tumori. >Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss)

【24h】

Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss)

机译：四肢非转移性骨肉瘤。甲氨蝶呤，顺铂，阿霉素和异环磷酰胺的新辅助化疗。意大利肉瘤小组的一项研究（ISG / OS-Oss）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background. Based on the results of the ISG/OS-1 study, the MAP regimen (methotrexate [MTX], doxorubicin [ADM] and cisplatin [CDP] with the addition of ifosfamide [IFO] in poor-responder patients) was investigated in patients with nonmetastatic osteosarcoma of the extremity (ISG/OS-Oss study).

机译：背景。根据ISG / OS-1研究的结果，在反应较弱的患者中研究了MAP方案（甲氨蝶呤[MTX]，阿霉素[ADM]和顺铂[CDP]以及异环磷酰胺[IFO]的添加）非转移性四肢骨肉瘤（ISG / OS-Oss研究）。

著录项

来源
《Tumori.》 |2014年第6期|共8页
作者
Ferrari Stefano; Meazza Cristina; Palmerini Emanuela; Tamburini Angela; Fagioli Franca; Cozza Raffaele; Ferraresi Virginia; Bisogno Gianni; Mascarin Maurizio; Cefalo Graziella; Manfrini Marco; Capanna Rodolfo; Biagini Roberto; Donati Davide; Picci Piero;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
osteosarcoma; neoadjuvant chemotherapy; methotrexate; tumor necrosis;

机译：骨肉瘤;新辅助化疗;甲氨蝶呤;肿瘤坏死;

相似文献

外文文献
中文文献
专利

1. Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss) [J] . Ferrari Stefano, Meazza Cristina, Palmerini Emanuela, Tumori. . 2014,第6期

机译：四肢非转移性骨肉瘤。甲氨蝶呤，顺铂，阿霉素和异环磷酰胺的新辅助化疗。意大利肉瘤小组的一项研究（ISG / OS-Oss）
2. Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: An Italian Sarcoma Group Trial ISG/OS-1 [J] . FerrariS., RuggieriP., CefaloG., Journal of Clinical Oncology . 2012,第17期

机译：甲氨蝶呤，顺铂和阿霉素联合或不联合异环磷酰胺在肢体非转移性骨肉瘤中的新辅助化疗：意大利肉瘤小组试验ISG / OS-1
3. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. [J] . Ferrari S, Smeland S, Mercuri M, Journal of Clinical Oncology . 2005,第34期

机译：大剂量异环磷酰胺，大剂量甲氨蝶呤，顺铂和阿霉素的新辅助化疗对肢体局限性骨肉瘤的患者：意大利和斯堪的纳维亚肉瘤团体的联合研究。
4. Assessing the Percent of Necrosis after Neoadjuvant Chemotherapy with 24hr Infusional Cisplatin/3 Days Doxorubicin Intermittent with Ifosfamide-Doxorubicin for Osteosarcoma [O] . Mozhgan Aalam Samimi, Nooshin Mirkheshti, Abdolreza Pazouki 2014

机译：评估新辅助化疗与24小时输注顺铂/ 3天阿霉素与异环磷酰胺-阿霉素间歇治疗骨肉瘤后的坏死百分比
5. Tolerability and Efficacy of Neoadjuvant Chemotherapy with a Tri-Weekly Interval Methotrexate, Doxorubicin, Vinblastine, and Cisplatin Regimen for Patients with Locally Advanced Bladder Cancer [O] . Satoko Arai, Tomohiko Hara, Yoshiyuki Matsui, 2018

机译：Neoadjuvant化疗与三当时间隔甲氨蝶呤，多柔比星，长春碱和顺铂治疗患者局部晚期膀胱癌患者的耐受性和有效性

Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss)

摘要

著录项

相似文献

相关主题

期刊订阅